Interní Med. 2011; 13(10): 406-408

Upper dyspeptic syndrome - guidelines for practice

doc.MUDr.Bohumil Seifert, Ph.D.
Univerzita Karlova, 1. lékařská fakulta, Ústav všeobecného lékařství 1. LF UK v Praze

Dyspeptic complaints are among the most common reasons to see a physician and their diagnosis and treatment represents a major

economic burden. Specialized care for patients with gastrointestinal complaints is not to be simplified in that there are gastroenterology

specialists to treat dyspeptic complaints. Given the prevalence of these complaints and particularly the predominance of functional

disorders, the role of general practitioners and their competency in this area is significant and urgent as is the need to optimize interdisciplinary

cooperation. In the recent years, a lot of effort has been put into creating guidelines and algorithms for patients with these

complaints in an attempt to rationalize approaches. For this year, the Society of General Practice of the Czech Medical Association of

J. E. Purkyně has ordered a second update of guidelines for general practitioners on Upper and Lower Dyspeptic Syndrome and a team

of authors has commenced work. The present article provides an overview of suggestions for update in four key areas: functional dyspepsia,

peptic ulcer, gastroesophageal reflux disease, and nonsteroidal anti-inflammatory drug gastropathy.

drug gastropathy.

Keywords: general practitioner, gastrointestinal disease, dyspepsia, peptic ulcer, gastroesophageal reflux disease, nonsteroidal antiinflammatory

Published: October 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Seifert B. Upper dyspeptic syndrome - guidelines for practice. Interní Med. 2011;13(10):406-408.
Download citation

References

  1. www.svl.cz
  2. Seifert B, Dítě P, Bureš J, et al. Doporučený diagnostický a léčebný postup pro všeobecné praktické lékaře. Dyspepsie horního typu, novelizace 2008.
  3. Dušek L, Mužík J, Kubásek M, et al. Epidemiologie zhoubných nádorů v České republice [online]. Masarykova univerzita [2005] [cit. 2011-2-03]. Dostupný z WWW: http://www.svod.cz. Verze 7.0 [2007].
  4. Alander T, Svardsud K, Agreus L. Functional gastrointestinal disorder is associated with increased non-gastrointestinal healthcare consumption in the general population. International Journal of Clinical Practice 2008; 62(2): 234-240. Go to original source... Go to PubMed...
  5. Seifert B, Beneš V, Struk P. Dyspepsie v primární péči. Závěrečná zpráva projektu. Rozvoj integrované primární zdravotní péče. 2000; PHARE CZ 9703-01-02-06-010042.
  6. Jones R, Lydeard S. Prevalence of symptoms of dyspepsia in the community. British Medical Journal 1989; 7, 298(6665): 30-32. Go to original source... Go to PubMed...
  7. Rejchrt S, a kol. Prevalence a sociodemografická charakteristika dyspepsie v České republice. Hradec Králové: Nucleus 2005.
  8. Bureš J, et al. Epidemiology of Helicabacter pylori Infection in the Czech Republic. Blackwell Publishing 2006; Helicobacter 11: 56-65. Go to original source... Go to PubMed...
  9. The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-based Consensus. Am J Gastroenterol 2006; 101: 1-21.
  10. Gilard M, Arnaud B, Cornily JC, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. J Am Coll Cardiol 2008; 51: 256-260. Go to original source... Go to PubMed...
  11. Juurlink DN, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009; 180(7): 713-718. Go to original source... Go to PubMed...
  12. Ray WA, Murray KT, Griffin MR, et al. Outcomes With Concurrent Use of Clopidogrel With Proton Pump Inhibitors. Ann Intern Med 2010; 152: 337-355. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.